You are currently on the new version of our website. Access the old version .

236 Results Found

  • Systematic Review
  • Open Access
3 Citations
3,072 Views
24 Pages

18 August 2023

Major depressive disorder (MDD) is a medical condition involving persistent sadness and loss of interest; however, conventional treatments with antidepressants and cognitive behavioral therapy have limitations. Based on the pathogenesis of MDD, treat...

  • Article
  • Open Access
5 Citations
2,662 Views
11 Pages

Effects of the Interaction between Affective Temperaments and BIS/BAS on Depressive Symptoms in Individuals with Major Depressive Disorder

  • Kuniyoshi Toyoshima,
  • Jiro Masuya,
  • Miki Ono,
  • Mina Honyashiki,
  • Shogo Hashimoto,
  • Ichiro Kusumi and
  • Takeshi Inoue

Depressive symptoms (DepS) associated with major depressive disorder (MDD) are influenced by affective temperaments (ATs), behavioral inhibition system (BIS), and behavioral activation system (BAS). However, the effect of interactions between ATs and...

  • Communication
  • Open Access
6 Citations
2,829 Views
10 Pages

28 October 2020

Mismatch negativity (MMN) and loudness dependence of auditory evoked potentials (LDAEP), which are event-related potentials, have been investigated as biomarkers. MMN indicates the pre-attentive function, while LDAEP may be an index of central seroto...

  • Article
  • Open Access
2,966 Views
12 Pages

Serotonin Transporter mRNA Expression Is Reduced in the Peripheral Blood Mononuclear Cells of Subjects with Major Depression but Normal in Fibromyalgia

  • Gaël Villanueva-Charbonneau,
  • Stéphane Potvin,
  • Serge Marchand,
  • Alexander McIntyre,
  • Diane McIntosh,
  • Alain Bissonnette,
  • Alain Gendron,
  • Charles-Édouard Giguère,
  • Marie-Ève Koué and
  • Édouard Kouassi

20 October 2023

Background: Fibromyalgia (FM) and major depression disorder (MDD) frequently co-occur. Both disorders may share common serotonergic alterations, although there is less evidence of such alterations in FM. It is also unclear as to whether these alterat...

  • Article
  • Open Access
11 Citations
2,631 Views
16 Pages

Due to the high comorbidity of Parkinson’s disease (PD) with major depressive disorder (MDD) and the involvement of sphingolipids in both conditions, we investigated the peripheral expression levels of three primarily PD-associated genes: &alph...

  • Article
  • Open Access
32 Citations
8,801 Views
13 Pages

Background: The study aimed to explore the psychometric properties of two versions of the Patient Health Questionnaires (PHQ-9 and PHQ-2) on screening for Major Depressive Disorder (MDD) among Spanish-speaking Latin American adult immigrants in Santi...

  • Article
  • Open Access
42 Citations
5,557 Views
13 Pages

Factors Associated with the Risk of Developing Coronary Artery Disease in Medicated Patients with Major Depressive Disorder

  • Roger C. M. Ho,
  • Anna C. Chua,
  • Bach X. Tran,
  • Carol C. Choo,
  • Syeda Fabeha Husain,
  • Giang T. Vu,
  • Roger S. McIntyre and
  • Cyrus S. H. Ho

Background: The aim of this study was to identify factors associated with high Framingham Risk Score (FRS) in medicated patients with major depressive disorder (MDD). Methods: We examined 61 medicated patients with MDD (mean age 37.77 ± 7.67,...

  • Review
  • Open Access
119 Citations
18,079 Views
16 Pages

Effects of Meditative Movements on Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

  • Liye Zou,
  • Albert Yeung,
  • Chunxiao Li,
  • Gao-Xia Wei,
  • Kevin W. Chen,
  • Patricia Anne Kinser,
  • Jessie S. M. Chan and
  • Zhanbing Ren

1 August 2018

Background: Tai Chi, Qigong, and Yoga are recognized as the most popular complementary approaches for alleviating musculoskeletal pain, improving sleep quality, and reducing blood pressure. The therapeutic effects of these meditative movements for tr...

  • Article
  • Open Access
8 Citations
5,268 Views
10 Pages

21 June 2020

The long-term use of benzodiazepines is not recommended for the treatment of major depressive disorder (MDD) due to the risk of adverse effects, including dependence, falls, dementia, mortality and the lack of evidence of effectiveness for symptoms o...

  • Article
  • Open Access
4 Citations
2,203 Views
10 Pages

Cardiolipin Antibody: A Potential Biomarker for Depression

  • Renzo Costa,
  • Evangelia Fatourou,
  • Debra Hoppensteadt,
  • Jawed Fareed and
  • Angelos Halaris

24 October 2022

Background: Inflammation plays a pivotal role in the etiopathology of Major Depressive Disorder (MDD), at least in a subset of patients. It is crucial to first establish which specific inflammatory biomarkers are of clinical utility. Anti-cardiolipin...

  • Article
  • Open Access
7 Citations
3,764 Views
15 Pages

Plasma Brain-Derived Neurotrophic Factor (BDNF) Levels and BDNF Promoters’ DNA Methylation in Workers Exposed to Occupational Stress and Suffering from Psychiatric Disorders

  • Antonello Veltri,
  • Vanessa Nicolì,
  • Riccardo Marino,
  • Filomena Rea,
  • Martina Corsi,
  • Martina Chiumiento,
  • Marianna Giangreco,
  • Fabrizio Caldi,
  • Giovanni Guglielmi and
  • Rodolfo Buselli
  • + 2 authors

30 October 2024

Introduction: Decreased plasma BDNF (pBDNF) levels have been proposed as a biomarker in the illness phases of mood disorders. This cross-sectional study aimed to evaluate the pBDNF and BDNF promoters’ DNA methylation levels in workers exposed t...

  • Article
  • Open Access
8 Citations
3,103 Views
12 Pages

Discovery of Screening Biomarkers for Major Depressive Disorder in Remission by Proteomic Approach

  • Hyebin Choi,
  • Sora Mun,
  • Eun-Jeong Joo,
  • Kyu Young Lee,
  • Hee-Gyoo Kang and
  • Jiyeong Lee

Major depressive disorder (MDD) is a common disorder involving depressive mood and decreased motivation. Due to its high heterogeneity, novel biomarkers are required to diagnose MDD. In this study, a proteomic method was used to identify a new MDD bi...

  • Article
  • Open Access
10 Citations
3,762 Views
9 Pages

24 October 2018

Objective: To compare the prevalence of depression in the four most common cancers in the US and evaluate differences in demographics and hospital outcomes. Methods: This was a cross-sectional study using the Nationwide Inpatient Sample (2010–2...

  • Review
  • Open Access
912 Views
16 Pages

Copper Dysregulation in Major Depression: A Systematic Review and Meta-Analytic Evidence for a Putative Trait Marker

  • Rosanna Squitti,
  • Mariacarla Ventriglia,
  • Ilaria Simonelli,
  • Cristian Bonvicini,
  • Daniela Crescenti,
  • Barbara Borroni,
  • Mauro Rongioletti and
  • Roberta Ghidoni

22 September 2025

Major depressive disorder (MDD) is a leading contributor to global disability. Despite advances in neurobiological research, no reliable peripheral biomarkers are currently available for diagnosis or monitoring. Copper (Cu), an essential trace elemen...

  • Article
  • Open Access
5 Citations
2,420 Views
11 Pages

30 December 2023

Overweight and obesity are frequent symptoms in patients with major depressive disorder (MDD) and abnormal lipid metabolism (ALM). There are no studies on the rate, risk factors, and underlying mechanisms of overweight/obesity in Chinese patients wit...

  • Article
  • Open Access
16 Citations
4,148 Views
15 Pages

A Multi-Trait Association Analysis of Brain Disorders and Platelet Traits Identifies Novel Susceptibility Loci for Major Depression, Alzheimer’s and Parkinson’s Disease

  • Alfonsina Tirozzi,
  • Miriam Shasa Quiccione,
  • Chiara Cerletti,
  • Maria Benedetta Donati,
  • Giovanni de Gaetano,
  • Licia Iacoviello and
  • Alessandro Gialluisi

6 January 2023

Among candidate neurodegenerative/neuropsychiatric risk-predictive biomarkers, platelet count, mean platelet volume and platelet distribution width have been associated with the risk of major depressive disorder (MDD), Alzheimer’s disease (AD)...

  • Article
  • Open Access
10 Citations
7,687 Views
18 Pages

28 December 2022

Many individuals are suffering from depression, and various improvements are being proposed. This study was conducted on young people diagnosed with depression and aimed to assess the effects of flavonoid-rich orange juice on the major depressive dis...

  • Article
  • Open Access
8 Citations
4,256 Views
12 Pages

30 July 2021

Healthy diet is essential to type 2 diabetes mellitus (T2DM) prevention for women with previous gestational diabetes mellitus (GDM). To evaluate the effect of a lifestyle intervention program on diet quality for rural women who were previously diagno...

  • Article
  • Open Access
7 Citations
2,784 Views
13 Pages

13 November 2024

Major Depressive Disorder (MDD) is a neuropsychiatric condition whose neurobiological characteristics include alterations in brain plasticity, modulated by Brain-Derived Neurotrophic Factor (BDNF). In animal models, environmental enrichment promotes...

  • Article
  • Open Access
9 Citations
3,400 Views
13 Pages

Immune dysregulation is implicated in the pathophysiology of both bipolar and major depressive disorder, while immune cell ratios (IRCs) have recently been proposed as clinically applicable immune biomarkers. We investigated IRCs differences in affec...

  • Article
  • Open Access
1 Citations
3,079 Views
9 Pages

Study on the Role of Inflammatory Markers and Type D Personality on Symptom Profiles and Severity in Patients with Major Depressive Disorder

  • Ileana Enatescu,
  • Raluka Kalinovic,
  • Catalina Giurgi-Oncu,
  • Vladimir Poroch,
  • Ioan Sorin Stratulat,
  • Gabriela Vlad,
  • Oana Neda-Stepan,
  • Mihaela Simu,
  • Ion Papava and
  • Virgil Radu Enatescu
  • + 1 author

13 August 2020

The high rates of chronicity and recurrences account for the limited efficacy of current antidepressants, conceived based on the current neurobiological hypotheses, in reaching the full clinical and functional remission of major depressed (MDD) patie...

  • Article
  • Open Access
11 Citations
3,401 Views
9 Pages

7 December 2021

The interaction between the endocrine system and inflammation is crucial pathogenesis of depression. Our study aimed at exploring the possible relationship between sex hormones and growth differentiation factor-15 (GDF-15), a common indicator of infl...

  • Article
  • Open Access
3 Citations
4,298 Views
15 Pages

Circadian and Sleep Modulation of Dreaming in Women with Major Depression

  • Angelina Birchler-Pedross,
  • Sylvia Frey,
  • Christian Cajochen and
  • Sarah L. Chellappa

28 February 2022

Growing evidence indicates an association between reduced dream recall and depressive symptomatology. Here, we tested the prediction that reduced dream recall in individuals experiencing major depressive disorder (MDD) is due to alterations in circad...

  • Article
  • Open Access
411 Views
14 Pages

Blood Concentrations of Folic Acid and Homocysteine Are Associated with Treatment-Resistant Depression Among Female Depressed Patients

  • Iva Radoš,
  • Zrinka Vuksan-Ćusa,
  • Jakov Milić,
  • Marina Šagud,
  • Ana Lončar Vrančić,
  • Nenad Jakšić,
  • Bjanka Vuksan-Ćusa and
  • Nela Pivac

1 January 2026

Treatment-resistant depression (TRD) is a subtype of major depressive disorder (MDD) that fails to respond to first-line pharmacotherapy. This cross-sectional study compared blood concentrations of folic acid, vitamin B12, and homocysteine between fe...

  • Article
  • Open Access
15 Citations
3,843 Views
10 Pages

Structural Changes in Hippocampal Subfields in Patients with Continuous Remission of Drug-Naive Major Depressive Disorder

  • Asuka Katsuki,
  • Keita Watanabe,
  • LeHoa Nguyen,
  • Yuka Otsuka,
  • Ryohei Igata,
  • Atsuko Ikenouchi,
  • Shingo Kakeda,
  • Yukunori Korogi and
  • Reiji Yoshimura

Objective: Hippocampal volume is reduced in patients with major depressive disorder (MDD) compared with healthy controls. The hippocampus is a limbic structure that has a critical role in MDD. The aim of the present study was to investigate the chang...

  • Article
  • Open Access
108 Citations
12,171 Views
11 Pages

COVID-19 Pandemic and Mental Health: Prevalence and Correlates of New-Onset Obsessive-Compulsive Symptoms in a Canadian Province

  • Adam Abba-Aji,
  • Daniel Li,
  • Marianne Hrabok,
  • Reham Shalaby,
  • April Gusnowski,
  • Wesley Vuong,
  • Shireen Surood,
  • Nnamdi Nkire,
  • Xin-Min Li and
  • Vincent I.O. Agyapong

Background: This cross-sectional online survey investigates the prevalence of obsessive-compulsive disorder (OCD) symptoms at an early stage of the COVID-19 pandemic in Canada. Methods: OCD symptoms, moderate/high stress, likely generalized anxiety d...

  • Article
  • Open Access
2 Citations
1,722 Views
20 Pages

Exploring Male-Specific Synaptic Plasticity in Major Depressive Disorder: A Single-Nucleus Transcriptomic Analysis Using Bioinformatics Methods

  • Ji Chen,
  • Xiumei Zhu,
  • Fan Yang,
  • Yanan Liu,
  • Huajie Ba,
  • Ping Huang,
  • Hongyan Wang,
  • Yingnan Bian,
  • Chengtao Li and
  • Suhua Zhang

Major depressive disorder (MDD) is a complex psychiatric illness, with synaptic plasticity playing a key role in its pathology. Our study aims to investigate the molecular basis of MDD by analyzing synaptic plasticity-related gene expression at the s...

  • Article
  • Open Access
12 Citations
7,118 Views
18 Pages

Multi-Omics Characterization of Early- and Adult-Onset Major Depressive Disorder

  • Caroline W. Grant,
  • Erin F. Barreto,
  • Rakesh Kumar,
  • Rima Kaddurah-Daouk,
  • Michelle Skime,
  • Taryn Mayes,
  • Thomas Carmody,
  • Joanna Biernacka,
  • Liewei Wang and
  • Arjun P. Athreya
  • + 3 authors

6 March 2022

Age at depressive onset (AAO) corresponds to unique symptomatology and clinical outcomes. Integration of genome-wide association study (GWAS) results with additional “omic” measures to evaluate AAO has not been reported and may reveal nov...

  • Article
  • Open Access
1 Citations
797 Views
14 Pages

A Post-Hoc Analysis of Depressive Disorders in Patients with Type 2 Diabetes

  • Yegan Pillay,
  • W. Guyton Hornsby,
  • Chandan K. Saha,
  • Jay Shubrook,
  • Kent A. Crick,
  • Ziyi Yang,
  • Kieren Mather and
  • Mary de Groot

Background/Objectives: This study is an investigation of the occurrence, remission and recurrence of major depressive disorders (MDDs) in adults with type 2 diabetes (T2DM). Methods: Interviews were conducted with individuals (N = 176) who met the cr...

  • Article
  • Open Access
943 Views
11 Pages

Unveiling the Interplay of EBV, HSV-1, and Inflammatory Biomarkers in Psychiatric Disorders

  • Özer Akgül,
  • Ömer Faruk Demirel,
  • İlker Tosun,
  • Yasin Kavla,
  • Mehmet Murat Kirpinar,
  • Burcu Sapmaz,
  • Gülçin Şenyiğit,
  • Reyhan Çalişkan and
  • Yaşar Ali Öner

24 September 2025

Background/Objectives: Schizophrenia (SCH), bipolar disorder (BPD), and major depressive disorder (MDD) are increasingly viewed as neuroimmune disorders shaped by viral exposure and inflammation. Disorder-specific immunovirological profiles, however,...

  • Article
  • Open Access
68 Citations
5,749 Views
12 Pages

27 June 2019

Chronic inflammation and abnormalities in Toll-like receptor (TLR) signaling pathways are associated with major depressive disorder (MDD). Our previous work reported that impaired negative regulators for the TLR pathways are associated with MDD. This...

  • Article
  • Open Access
5 Citations
3,207 Views
18 Pages

Exploring Differences in Dietary Diversity and Micronutrient Adequacy between Costa Rican and Mexican Adolescents

  • Rafael Monge-Rojas,
  • Rulamán Vargas-Quesada,
  • Joaquín Alejandro Marrón-Ponce,
  • Tania G. Sánchez-Pimienta,
  • Carolina Batis and
  • Sonia Rodríguez-Ramírez

3 January 2024

Diet diversity becomes especially relevant during adolescence to satisfy the adequate micronutrient intake. Diet diversity (DD) and micronutrient probability of adequacy (PA) were studied in 818 Costa Rican (CR) and 1202 Mexican (MX) adolescents aged...

  • Article
  • Open Access
9 Citations
4,450 Views
16 Pages

(1) Background: Prediction of treatment outcome has been one of the core objectives in clinical research of patients with major depressive disorder (MDD). This study explored the possibility of event-related potential (ERP) markers to predict antidep...

  • Article
  • Open Access
3 Citations
3,175 Views
17 Pages

17 January 2024

Depression and vitamin D deficiency are often co-occurring pathologies, the common pathogenetic ground of which includes an augmented inflammatory response. However, the molecular details of this relationship remain unclear. Here, we used a bioinform...

  • Article
  • Open Access
18 Citations
5,043 Views
14 Pages

Background: Studies have implicated hypofrontality in the pathogenesis of impaired theory of mind (ToM) and executive function (EF) in major depressive disorder (MDD). These symptoms are usually resistant to treatment. Repetitive transcranial magneti...

  • Article
  • Open Access
3 Citations
4,507 Views
15 Pages

Poor Adherence to the WHO Guidelines on Feeding Practices Increases the Risk for Respiratory Infections in Surinamese Preschool Children

  • Jill R. Wormer,
  • Arti Shankar,
  • Michael Boele Van Hensbroek,
  • Ashna D. Hindori-Mohangoo,
  • Hannah Covert,
  • Maureen Y. Lichtveld and
  • Wilco C. W. R. Zijlmans

Poor feeding practices in infants and young children may lead to malnutrition, which, in turn, is associated with an increased risk of infectious diseases, such as respiratory tract infections (RTIs), a leading cause of under-five mortality. We explo...

  • Article
  • Open Access
14 Citations
4,107 Views
9 Pages

Detecting Depression Using Single-Channel EEG and Graph Methods

  • Guohun Zhu,
  • Tong Qiu,
  • Yi Ding,
  • Shang Gao,
  • Nan Zhao,
  • Feng Liu,
  • Xujuan Zhou and
  • Raj Gururajan

8 November 2022

Objective: This paper applies graph methods to distinguish major depression disorder (MDD) and healthy (H) subjects using the graph features of single-channel electroencephalogram (EEG) signals. Methods: Four network features—graph entropy, mea...

  • Article
  • Open Access
16 Citations
3,872 Views
12 Pages

Quantification of Minimal Disease by Digital PCR in ALK-Positive Anaplastic Large Cell Lymphoma: A Step towards Risk Stratification in International Trials?

  • Christine Damm-Welk,
  • Federica Lovisa,
  • Giorgia Contarini,
  • Jette Lüdersen,
  • Elisa Carraro,
  • Fabian Knörr,
  • Jan Förster,
  • Martin Zimmermann,
  • Alessandra Sala and
  • Lara Mussolin
  • + 3 authors

27 March 2022

Minimal disseminated and residual disease (MDD/MRD) analyzed by qualitative PCR for NPM-ALK fusion transcripts are validated prognostic factors in pediatric ALK-positive anaplastic large cell lymphoma (ALCL). Although potentially promising, MDD quant...

  • Article
  • Open Access
5 Citations
5,655 Views
13 Pages

Mid-Luteal Progesterone Is Inversely Associated with Premenstrual Food Cravings

  • Ajna Hamidovic,
  • Fatimata Soumare,
  • Aamina Naveed and
  • John Davis

22 February 2023

It is not clear whether progesterone and estradiol associate with premenstrual food cravings, which significantly contribute to cardiometabolic adverse effects associated with obesity. We sought to investigate this question in the present study based...

  • Article
  • Open Access
2 Citations
3,594 Views
12 Pages

Individual and Combined Effect of MAO-A/MAO-B Gene Variants and Adverse Childhood Experiences on the Severity of Major Depressive Disorder

  • Christian Gabriel Toledo-Lozano,
  • Luz Berenice López-Hernández,
  • Juan Antonio Suárez-Cuenca,
  • Luis Villalobos-Gallegos,
  • Dulce Adeí Jiménez-Hernández,
  • Sofía Lizeth Alcaraz-Estrada,
  • Paul Mondragón-Terán,
  • Lilia Joya-Laureano,
  • Ramón Mauricio Coral-Vázquez and
  • Silvia García

26 September 2023

Background: Major depressive disorder (MDD) is a mood disorder with a high prevalence worldwide that causes disability and, in some cases, suicide. Although environmental factors play a crucial role in this disease, other biological factors may predi...

  • Article
  • Open Access
1,073 Views
17 Pages

28 June 2025

Background/Objectives: There is limited data on well-documented comorbidities with polysomnography (PSG)/multiple sleep latency test (MSLT) findings in idiopathic hypersomnia (IH). We aimed to characterize the clinical, PSG/MSLT characteristics of IH...

  • Article
  • Open Access
16 Citations
5,514 Views
11 Pages

Ramadan Fasting Improves Body Composition without Exacerbating Depression in Males with Diagnosed Major Depressive Disorders

  • Haitham Jahrami,
  • Ahmed S. BaHammam,
  • Eman Ahmed Haji,
  • Nicola L. Bragazzi,
  • Ihab Rakha,
  • Amani Alsabbagh,
  • Boya Nugraha and
  • Stefan M. Pasiakos

7 August 2021

Background: Ramadan fasting (RF) is a form of intermittent fasting that generally improves body composition and related metabolic profiles. Whether RF exacerbates depressive symptomatology in individuals diagnosed with major depressive disorder (MDD)...

  • Article
  • Open Access
2,940 Views
16 Pages

Predicting Regional Cerebral Blood Flow Using Voxel-Wise Resting-State Functional MRI

  • Hongjie Ke,
  • Bhim M. Adhikari,
  • Yezhi Pan,
  • David B. Keator,
  • Daniel Amen,
  • Si Gao,
  • Yizhou Ma,
  • Paul M. Thompson,
  • Neda Jahanshad and
  • Peter Kochunov
  • + 7 authors

23 August 2025

Background: Regional cerebral blood flow (rCBF) is a putative biomarker for neuropsychiatric disorders, including major depressive disorder (MDD). Methods: Here, we show that rCBF can be predicted from resting-state functional MRI (rsfMRI) at the vox...

  • Article
  • Open Access
4 Citations
3,184 Views
16 Pages

8 January 2021

Along with sanitation and hygiene, water is a well-known driver of child undernutrition. However, a more direct role of household (HH) water access in shaping dietary diversity remains unexplored. We assessed the association between HH water access a...

  • Article
  • Open Access
609 Views
18 Pages

Lower ANXA3 Levels May Be Related to Major Depressive Disorder

  • Mine Büşra Bozkürk,
  • Kadir Özdel,
  • Bilge Ozan Çiçek,
  • Özkan Önder,
  • Selin Yıldız and
  • Alpaslan Öztürk

17 September 2025

Annexin A3 (ANXA3) is a calcium-binding protein that plays a role in membrane phospholipid metabolism and inflammation, and significant alterations have been shown in some psychotic disorders. Because its association with major depressive disorder (M...

  • Systematic Review
  • Open Access
21 Citations
4,592 Views
19 Pages

23 September 2021

Probiotics were shown to act positively on gut–brain axis signaling. We aimed to assess the effect of the administration of a new class of probiotics—psychobiotics—using data from individual psychometric scales, markers of the immune system and neuro...

  • Article
  • Open Access
5 Citations
3,085 Views
9 Pages

26 September 2019

Background: Proinflammatory cytokines, such as tumor necrosis factor-alpha (TNF-α), are associated with the pathophysiology of major depressive disorder (MDD). Several studies have reported that increased TNF-α might be associated with tr...

  • Review
  • Open Access
19 Citations
11,586 Views
18 Pages

Substance P (SP) plays a crucial role in pain modulation, with significant implications for major depressive disorder (MDD), anxiety disorders, and post-traumatic stress disorder (PTSD). Elevated SP levels are linked to heightened pain sensitivity an...

  • Article
  • Open Access
665 Views
15 Pages

Disentangling the Effects of Suicide Attempts and Psychiatric Diagnosis Based on a Genotype-Informed Dynamic Model of the Serotonin Presynapse

  • Lana Radenković,
  • Maja Pantović-Stefanović,
  • Goran Brajušković,
  • Maja Ivković,
  • Dušanka Savić-Pavićević and
  • Jovan Pešović

26 September 2025

Background: Suicide attempts often co-occur with bipolar disorder (BD), major depressive disorder (MDD), and schizophrenia (SCH). Although impairments of the serotonin (5-HT) system have been associated with suicide attempts, it remains unclear wheth...

  • Article
  • Open Access
7,084 Views
16 Pages

Reward System EEG–fMRI-Pattern Neurofeedback for Major Depressive Disorder with Anhedonia: A Multicenter Pilot Study

  • Daniela Amital,
  • Raz Gross,
  • Nadav Goldental,
  • Eyal Fruchter,
  • Haya Yaron-Wachtel,
  • Aron Tendler,
  • Yaki Stern,
  • Lisa Deutsch,
  • Jeffrey D. Voigt and
  • Haggai Sharon
  • + 2 authors

Background/Objectives: Up to 75% of patients with major depressive disorder (MDD) exhibit persistent anhedonia symptoms related to abnormalities in the positive valence system. Cumulative evidence points to brain dysfunction in the reward system (RS)...

of 5